Log in to save to my catalogue

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell developmen...

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell developmen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_04c9903c45a041a292092f38195e3bde

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development

About this item

Full title

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-09, Vol.14 (1), p.6119-19, Article 6119

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The coding variant (p.Arg192His) in the transcription factor
PAX4
is associated with an altered risk for type 2 diabetes (T2D) in East Asian populations. In mice,
Pax4
is essential for beta cell formation but its role on human beta cell development and/or function is unknown. Participants carrying the PAX4 p.His192 allele exhibited decr...

Alternative Titles

Full title

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_04c9903c45a041a292092f38195e3bde

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_04c9903c45a041a292092f38195e3bde

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-41860-z

How to access this item